Regulation of the interleukin-5 receptor α-subunit on peripheral blood eosinophils from healthy subjects

Clinical and Experimental Immunology

Volumn 131, Issue 1, 2003, Pages 75-81

  Hellman, Cecilia ^a,b   Hallden G ^a   Hylander, B ^a   Lundahl, J ^c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c NONE

Author keywords

CD69; Eosinophils; GM CSF; IL 5; IL 5 receptor alpha

Indexed keywords

CD69 ANTIGEN; DIALYSIS FLUID; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 5 RECEPTOR; NEUTRALIZING ANTIBODY; RECEPTOR SUBUNIT; RECOMBINANT INTERLEUKIN 5;

ADULT; AGED; ARTICLE; AUTOCRINE EFFECT; BACTERIAL PERITONITIS; CASE REPORT; CELL FREE SYSTEM; CONTROLLED STUDY; EOSINOPHIL; EOSINOPHILIA; FEMALE; HUMAN; HUMAN CELL; MALE; NORMAL HUMAN; PERITONEAL DIALYSIS; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION;

AGED; ANTIBODIES, MONOCLONAL; ASCITIC FLUID; CELLS, CULTURED; DEPRESSION, CHEMICAL; EOSINOPHILIA; EOSINOPHILS; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-5; MALE; MIDDLE AGED; PROTEIN SUBUNITS; RECOMBINANT PROTEINS;

EID: 0037232331     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2003.02051.x     Document Type: Article

References (39)

1. Bousquet J, Chanez P, Lacoste JY et al. Eosinophilic inflammation in asthma. N Engl J Med 1990; 323:1033-9.
2. Griffin E, Håkansson L, Formgren H, Jörgensen K, Peterson C, Venge P. Blood eosinophil number and activity in relation to lung function in patients with asthma and with eosinophilia. J Allergy Clin Immunol 1991; 87:548-57.
3. Janson C, Herala M. Blood eosinophil count as risk factor for relapse in acute asthma. Respir Med 1992; 86:101-4.
4. Halldén G, Hellman C, Grönneberg R, Lundahl J. Increased levels of IL-5 positive peripheral blood eosinophils and lymphocytes in mild asthmatics after allergen inhalation provocation. Clin Exp Allergy 1999; 29:595-603.
5. Zimmerman B, Lanner A, Enander I, Zimmerman RS, Peterson CGB, Ahlstedt S. Total blood eosinophils, serum eosinophil cationic protein and eosinophil protein X in childhood asthma: relation to disease status and therapy. Clin Exp Allergy 1993; 23:564-70.
6. Wardlaw AJ, Dunnette S, Gleich GJ, Collins JV, Kay AB. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. Am Rev Respir Dis 1988; 137:62-9.
7. Warner JO, Marguet C, Rao R, Roche WR, Pohunek P. Inflammatory mechanisms in childhood asthma. Clin Exp Allergy 1998; 28:71-5.
8. Kirby J, Hargreave F, Gleich G, O'Byrne P. Bronchoalveolar cell profiles of asthmatic and nonasthmatic subjects. Am Rev Respir Dis 1987; 136:379-83.
9. Hargreave FE, Popov T, Kidney J, Dolovich J. Sputum measurements to assess airway inflammation in asthma. Allergy 1993; 48:81-3.
10. Butterworth AE. Cell mediated damage to helminths. Adv Parasitol 1984; 23:143-235.
11. Liesveld JL, Abboud CN. State of the art; the hypereosinophilic syndromes. Blood Rev 1991; 5:29-37.
12. Ejaz AA, Fitzpatrick PM, Durkin AJ, Wasiluk A, Haley WE, Goalen MJ, Ing TS, Zachariah PK. Pathophysiology of peritoneal fluid eosinophilia in peritoneal dialysis patients. Nephron 1999; 81:125-30.
13. Bachert C, Gevaert P, Holtappels G, Cuvelier C, van Cauwenberge P. Nasal polyposis: from cytokines to growth. Am J Rhinol 2000; 14:279-90.
14. Lowe D, Jorizzo J, Hutt MSR. Tumour associated eosinophilia, a review. J Clin Path 1981; 34:1343-8.
15. Wardlaw AJ. Eosinophils in the 1990s. new perspectives on their role in health and disease. Postgrad Med J 1994; 70:536-52.
16. Venge P. Epithelial injury by human eosinophils. Am Rev Respir Dis 1988; 138:54-7.
17. Chung KF, Barnes PJ. Cytokines in asthma. Thorax 1999; 54:825-57.
18. Walker C, Virchow CJ, Bruijnzeel PLB, Blaser K. T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma. J Immunol 1991; 146:1829-35.
19. Qymar K, Elsayed S, Bjerknes R. Serum eosinophil cationic protein and interleukin-5 in children with bronchial asthma and acute bronchiolitis. Pediatr Allergy Immunol 1996; 7:180-6.
20. Bentley AM, Meng Q, Robinson DS, Hamid Q, Kay AB, Durham SR. Increases in activated lymphocytes, eosinophils and cytokine mRNA expression for interleukin-5 and granulocyte/macrophages colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics. Am J Respir Cell Mol Biol 1993; 8:35-42.
21. Robinson DS, Hamid Q, Ying S et al. Predominant Th2-like broncho-alveolar T-lymphocytes population in atopic asthma. N Engl J Med 1992; 326:298-304.
22. Palframan RT, Collins PD, Williams TJ, Rankin SM. Eotaxin induces a rapid release of eosinophils and their progenitors from the bone marrow. Blood 1998; 91:2240-8.
23. Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 1996; 183:195-201.
24. Egan RW, Athwahl D, Chou CC et al. Inhibition of pulmonary eosinophilia and hyperreactivity by antibodies to interleukin-5. Int Arch Allergy Immunol 1995; 107:321-2.
25. Tavernier J, Devos R, Cornelis S, Tuypens T, Van der Heyden J, Fiers W, Plaetinck G. A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific alpha chain and a beta chain shared with the receptor for GM-CSF. Cell 1991; 66:1175-84.
26. Lopez AF, Elliott MJ, Woodcock J, Vadas MA. GM-CSF, IL-3 and IL-5: cross competition on human hematopoietic cells. Immunol Today 1992; 13:495-500.
27. Miyajima A, Kitamura T, Harada N, Yokota T, Arai K. Cytokine receptors and signal transduction. Annu Rev Immunol 1992; 10:295-331.
28. Tavernier J, Tuypens T, Plaetinck G, Verhee A, Fiers W, Devos R. Molecular basis of the membrane-anchored and two soluble isoforms of the human interleukin 5 receptor alpha subunit. Proc Natl Acad Sci USA 1992; 89:7041-5.
29. Tavernier J, Van der Heyden J, Verhee A et al. Interleukin 5 regulates the isoform expression of its own receptor alpha-subunit. Blood 2000; 95:1600-7.
30. Robinson DS, Damia R, Zeibecoglou K, Molet S, North J, Yamada T, Kay AB, Hamid Q. CD34 (+)/interleukin-5Ralpha messenger RNA+ cells in the bronchial mucosa in asthma: potential airway eosinophil progenitors. Am J Respir Cell Mol Biol 1999; 20:9-13.
31. Sehmi R, Wood LJ, Watson R, Foley R, Hamid Q, O'Byrne PM, Denburg JA. Allergen-induced increases in IL-5 receptor alpha-subunit expression on bone marrow-derived CD34+ cells from asthmatic subjects. A novel marker of progenitor cell commitment towards eosinophilic differentiation. J Clin Invest 1997; 100:2466-75.
32. Hellman C, Lundahl J, Hylander B, Halldén G. Phenotypic alterations of recruited eosinophils in 'peritoneal fluid eosinophilia'. Perit Dial Int 2000; 20:295-300.
33. Hansel TT, De Vries IJ, Iff T, Rihs S, Wandzilak M, Betz S, Blaser K, Walker C. An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. J Immunol Meth 1991; 145:105-10.
34. Wang P, Wu P, Cheewatrakoolpong B, Myers JG, Egan RW, Billah MM. Selective inhibition of IL-5 receptor alpha-chain gene transcription by IL-5, IL-3, and granulocyte-macrophage colony-stimulating factor in human blood eosinophils. J Immunol 1998; 160:4427-32.
35. Hartnell A, Robinson DS, Kay AB, Wardlaw AJ. CD69 is expressed by human eosinophils activated in vivo in asthma and in vitro by cytokines. Immunology 1993; 80:281-6.
36. Dubucquoi S, Desreumaux P, Janin A, Klein O, Goldman M, Tavernier J, Capron A, Capron M. Interleukin-5 synthesis by eosinophils association with granules and immunoglobulin-dependent secretion. J Exp Med 1994; 179:703-8.
37. Kankaanranta H, Lindsay MA, Giembycz MA, Zhang X, Moilanen E, Barnes PJ. Delayed eosinophil apoptosis in asthma. J Allergy Clin Immunol 2000; 106:77-83.
38. Tomaki M, Zhao LL, Lundahl J, Sjostrand M, Jordana M, Linden A, O'Byrne P, Lotvall J. Eosinophilopoiesis in a murine model of allergic airway eosinophilia: involvement of bone marrow IL-5 and IL-5 receptor alpha. J Immunol 2000; 165:4040-50.
39. Hellman C, Lönnkvist K, Hedlin G, Halldén G, Lundahl J. Down-regulated IL-5 receptor expression on peripheral blood eosinophils from budesonide-treated children with asthma. Allergy 2002; 57:323-8.